|
Title
|
Publication:
Journal & date
|
Key
improvements
|
|
Patient’s
preferences for video recorded information.
Effect of age, sex & ethnic group.
|
Thomas
R, Deary A, D. Stockton,
N DeZeeuw
. The Euro J Cancer Care. 1999; 8 83-86
|
We learnt from patients how they want information
and discovered deficits in our service.
|
|
Patient
information satisfaction following a diagnosis of cancer.
|
Deary
A, Thomas R. Annuls of Oncology. 1999, 9, S4, p143.
|
This is initial survey showed that patient were
dissatisfied
|
|
Anxiety
& Depression - Effect on patient’s preferences for info.
|
Thomas
R, Brown C, Stockton D. Anns of Onc 9, S4, pp 141.
|
Poor information is associated with Anxiety and
depression
|
|
Epo
for anaemia & qol in patients undergoing chemotherapy
|
H
Thomas, R Thomas, K McAdam,
S ESMO
, Nice 2002.
|
Epo improved anaemia and qol
|
|
Epoeitin:
Attitudes of community and hospital nursing staff.
|
A
Deary & R Thomas. EJC. Vol.35. Suppl.4. p.30
(ab. 92).
|
Epo use is well accepted by nursing staff
|
|
Do
patient's want the same information as the GP?
|
Kaminski
E, Deary A, Thomas R. EJC. 1997. 33, S8, 1391.
|
Most but not all and may frighten some.
|
|
Patient
preferences for a breast care nurse specialist.
|
Shingler
G, Smith S, Thomas R. EJC. 1997. Vol. 33, S8, 1397.
|
Accepted greater responsibilities of
breast care nurses
|
|
Patients
attitudes to a bespoke filofax information system.
|
Kaminski
E, Balusu R, Thomas R. EJC.
1997,. 33, S8, 1401.
|
Highly acceptable
|
|
Patient
information: A new structured information package.
|
DeZeeuz
N, Bulusu R, Thomas R. EJC.
1997. 33, S8, 1400
|
Feed back from patients helped us design this file
|
|
Where
do patients seek additional information after a diagnosis?
|
Shingler
G, Bulusu R, Thomas R. EJC. 1997. Vol. 33, Sup8, 1426.
|
Interesting insight into patient behaviour – word
of mouth
|
|
Why
Oncologist should provide a web site for their patients.
|
L
Dalton
and R Thomas. The EJC. 1999 35. S4. p.46
(ab. 164).
|
Uncontrolled internet sites. We developed
cancernet.co.uk
|
|
Forewarned
is forearmed – preparatory information on video cassette for
chemotherapy & radiotherapy - a randomised trial.
|
Thomas
R, Daly M, Perryman B,
Stockton
D. EJC 36 (2000) 1536-43. JCO
1999 ASCO): 1570 and EJC.;35.
S4. 275
|
We developed, then evaluated an information film,
free at
Bedford
distributed nationally by Cancer Bacup.
|
|
Developing
and evaluating a regional information strategy.
|
R
Thomas, C.Lockery. EJC 2001 vol 37, supp.2 pp 62
|
This review summarised our information strategies
|
|
Lyphpoma
Chemotherapy – an audit of neutrpenia, dose intensity, and gcsf use in
the
UK
|
R
Thomas, J.Sweetman, P Hoskins. EJC 2001 vol 37, supp.2 pp119
|
Showed the lack of maintaining dose intensity in
the
UK
with gcsf
|
|
Adjuvant
UK
breast cancer Chemotherapy – audit of neutrpenia, dose intensity &
gcsf.
|
R
Thomas and R Leonard. EJC 2001 vol 37, supp.2 pp61
|
Showed the diverse choice of regimens and lack of
maintenance of dose intensity
|
|
Lessons
Learnt from Raltitrexed – QA, Patient Education and Intensive Supportive
Drugs
|
R.J.
Thomas, M. Williams, J. Garcia-Vargas Clinical Oncology (2003) 00:1-6
|
For
colorectal cancer - Showed how to optimize tolerability, now
AstraZeneca guidelines
|
|
Examining
quality of life issues in relation to endocrine therapy for breast cancer.
|
Robert
Thomas. American Journal of Clinical Oncology 2003. Vol. 26, No. 4, p
S40-44
|
Showed the importance of letting patients have
greater input into their management.
|
|
RTO1
(MRC)
|
National
publication
|
Conformal Rxt better
|
|
Viktor
study (MRC)
|
National
Publication
|
Trial stopped - cardiac morbidity
|
|
Measuring
information strategies – developing an information satisfaction
questionnaire
|
Thomas
R, Kaminski E, Stanton E and Williams M. EJCC, 2004, 13, 65-70.
|
This questionnaire is now used internationally to
measure patient satisfaction to information
|
|
Giving
patients a choice improves qol: A multi-centre, investigator-blind, RCT of
letrozole v anastrozole
|
R.
Thomas, S. Godward, A. Makris, D. Bloomfield, A.M. Moody, M. Williams.
Clinical Oncology (2004) 16: 485-491.
|
Qol and tolerability can be improved by giving
patients a choice.
|
|
Patient
Information materials in Oncology: Are they needed and do they work?
|
Thomas
R, and H Thorton. Clinical
Oncology 1999;11: 225-231.
|
This review helped us understand the available
literature and improve our service
|
|
How
to deal with the complexities of patient consent?
|
Robert
Thomas. Pulse Clinical pp42-43
Dec2003.
|
This review helped us re-write our consent sheet.
|
|
The
changing face of informed consent
|
R
Thomas. B Journal of Can
Man.
Summer 2004 Vol. 1 No. 1.
|
This review also helped us re-write our consent
sheet.
|
|
What
are the costs of not using rhEPO to treat anaemia in cancer.
|
R
Thomas. Focus on anaemia in cancer. 2002, 3, 2, pp52-53.
|
This review identified the most cost effective
patients for epo
|
|
NICE
guidance on supportive and palliative care – Implications for Oncology
Teams.
|
Dr
R Thomas and Professor Alison Richardson. Clinical Oncology (2004) 16: 420-424.
|
Summarised the NICE guidelines for oncologist
|
|
The
NICE guidance on supportive and palliative care.
|
R
Thomas and Prof A Richardson. B J CM2004. 1. 3
|
Summarised the NICE guidelines for managers
|
|
Anaemia
fatigue and Epoeitin in Oncology
|
R
Thomas. British Journal of Cancer Management. April 2005.
|
A summary of the evidence helped us write the epo
guidance
|
|
PET
saves man
|
R
Thomas, M Williams & S Old. BJCM 2004 Vol. 1 No. 1
|
Highlighted the advantages of PET in colorectal
oncology
|
|
Information
– Local policies or a national strategy?
|
Thomas
R, British Medical Journal, 1999, vol 318. page 462
|
Comment on the importance of give local info for
local patients
|
|
The
Role of an Italian Volunteer Organisation.
|
F.
De lorenzo, R. Thomas,. L. 1998. Health communications.
|
Evaluated the Italian translation of our patient
information film.
|
|
An
open randomised trial of second-line endocrine therapy in breast cancer:
comparison of the letrozole and anastrozole.
|
C.
Rose, O. Vtoraya, A. Pluzanska, N. Davidson, M. R. Thomas, S. Johnson, et
al. EJC 39 (2003) 2318-2327
|
This head to head comparison suggested letrozole
has some advantages in terms of response.
|
|
Dietary
advice combined with a salicylate mineral and vitamin supplement (CV247)- a phase II study
|
R
Thomas, M Blades, M Williams Nutrition & Food Science. 2005 35 ,6,
436-451.
|
One of the first studies to suggest dietary
intervetion after cancer may affect progression
|
|
Avastin
saves the day
|
R
Thomas, A Eldin, BJCC, 2006, vol.2,no.2,
20-21
|
Interesting case report on the use of Avastin
|
|
Erbitux
the new team player
|
Y
Habba, R Thomas, D Skipper, M Rees, BJCM Jan 2006
|
Highlights a potential new role for erbitux
|
|
Complementary
& alternative medicine- evidence online
|
J
Richardson, K Pilkington R Thomas, BJCM 2005, 2;2,10-14
|
Reviewed the evidence for
CAM
therapies often taken by patients
|
|
Can
we move to a paperless information system?
|
A
Deary, R Thomas, M Williams ESMO 2005
|
Evaluated the attitudes & costs of an online
only system
|
|
Patients
in trials are more satisfied with their received info
|
R
Thomas, M Williams ESMO 2005
|
Reassures patients they are well informed in
clinical trials
|
|
Phase
111 study of gemcitabine and capecitabine for pancreas
|
National
publication
|
Help understand the chemo responsiveness of
pancreatic ca.
|
|
Can
switching to letrozole improve hot flushes, qol and patient preference
|
R
Thomas, L Walker, C Marshall,
San Antonio
breast cancer conference 2005 & ESMO Istanbul 2006
|
This study, with Hull & Cranfield Universities
highlights the qol benefits of changing to letrozole
|
|
Adjuvant
breast cancer drugs – blockbusters or bankrupters
|
R
Thomas, J Green, M Callam. BJCM Jan 2006
|
Reviewed evidence & cost of
Rx for our health economics study with
Cranfield
University
|
| Cost
effectiveness of adjuvant exemestane |
R
Thomas, M Williams, J Glen
ECCO 2007 and Nottingham Breast conference 2007 |
|
| Cost
effectiveness of adjuvant arimidex |
R
Thomas, M Williams, J Glen - ongoing
|
|
| Cost
effectiveness of adjuvant taxotere |
R
Thomas, M Williams, J Glen - ongoing
|
|
|
Can
switching to exemestane improve hot flushes, qol and patient preference
|
R
Thomas, L Walker, C Marshall,
ECCO 2007 - ongoing
|
This study, with Hull & Cranfield Universities
highlights the qol benefits of changing to exemestane
|
|
Double
blind randomised trial of CV247 v sodium salicylate in men with indolent
prostate cancer
|
R
Thomas, M Williams etc - ongoing
|
NCRN
trial designed at Bedford. completed and being analysed.
|
